RAUSERPIN Drug Patent Profile
✉ Email this page to a colleague
When do Rauserpin patents expire, and what generic alternatives are available?
Rauserpin is a drug marketed by Ferndale Labs and is included in one NDA.
The generic ingredient in RAUSERPIN is rauwolfia serpentina root. There are eight drug master file entries for this compound. Additional details are available on the rauwolfia serpentina root profile page.
Summary for RAUSERPIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 38 |
Patent Applications: | 214 |
Formulation / Manufacturing: | see details |
DailyMed Link: | RAUSERPIN at DailyMed |
US Patents and Regulatory Information for RAUSERPIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ferndale Labs | RAUSERPIN | rauwolfia serpentina root | TABLET;ORAL | 009926-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ferndale Labs | RAUSERPIN | rauwolfia serpentina root | TABLET;ORAL | 009926-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |